Skip to content

Ogur v1.2.0 — MVP-1 Stretch

Every PR merged since v1.1.0 (2026-08-13) carries the MVP-1-Stretch label — work that was not required to hold the MVP-1 gate but is complete and worth tagging on its own, ahead of the MVP-2 gate (due 2026-08-31).

New report packs

Two more Sanofi benchmark landscapes go live end to end:

  • cardiometabolic-rnai-001, built and served (#230), with the frontend retargeted off the dead nsclc-001 reads (#231).
  • obesity-rnai-001, in three stages: evidence base rescued and the benchmark registered (#232), the pack-replay seeder generalized from a GNS561-only script into landscape-parameterized pack_replay.py (#233), then the pack itself built and served (#234).

The CDE (chinadrugtrials.org.cn) evidence layer and its document-id manifest are committed to the archive (#229).

Report reading surface

A visual evidence-basis module with a sources-used disclosure block (#268), sources-first ordering and per-source marks in the sources roster. Auth-gated CSV exports of pack records with a live Downloads block (#266), exported cells neutralized against spreadsheet-formula injection. Report type sizes bumped per cofounder feedback (#264).

Feedback and collaboration

Comments now anchor to the report section a reviewer was reading, not just the document (#267) — bigger trigger, a c keyboard shortcut, an end-of-section nudge. General feedback and section comments track separately and no longer mislabel cross-variant comments. Named Genfit reviewer identities, one shared feedback timestamp formatter across all three feedback surfaces, and scripts/ops/reset_feedback.py to wipe feedback while leaving identities, sessions and grants intact (#271).

Content correction

The GNS561 pack's claim that every prior MAPK + autophagy attempt paired a MAPK inhibitor with hydroxychloroquine is now scoped to the lysosomal node — it was contradicted by Deciphera's inlexisertib (NCT04892017), a ULK½ + MAPK combination that used no hydroxychloroquine, in the same brief (#270, #273). The differentiation argument is unchanged; the overreach is not.

Also in this release

CI source-verification discipline prompt and the /integrate-expert-feedback skill (#215). Redeploy semantics documented with new make targets for provisioning (#274). A non-mapping records container at pack load now fails as its documented 503, not a server error (OGUR-78, #269, #272). inspect_sirna_seed's discovery-eval scorer was blind to the A22 patent recovery until gpatents was added to its SOURCES list (#275); abbreviated patent-registry applicant names now classify as research organizations (#276).

Full detail is in the [1.2.0] section of CHANGELOG.md.

Known limitations

Unchanged from v1.1.0 — Explore's open-ended live search is not built, the literature layer is primarily title and abstract where that is true the page says so, and login is not rate-limited.